Ontology highlight
ABSTRACT:
SUBMITTER: Di Rocco M
PROVIDER: S-EPMC5468985 | biostudies-literature | 2017 Jun
REPOSITORIES: biostudies-literature
Di Rocco Maja M Baujat Genevieve G Bertamino Marta M Brown Matthew M De Cunto Carmen L CL Delai Patricia L R PLR Eekhoff Elisabeth M W EMW Haga Nobuhiko N Hsiao Edward E Keen Richard R Morhart Rolf R Pignolo Robert J RJ Kaplan Frederick S FS
Orphanet journal of rare diseases 20170612 1
Fibrodysplasia ossificans progressiva (FOP), a disabling disorder of progressive heterotopic ossification (HEO), is caused by heterozygous gain-of- function mutations in Activin receptor A, type I (ACVR1, also known as ALK2), a bone morphogenetic protein (BMP) type I receptor. Presently, symptomatic management is possible, but no definitive treatments are available. Although extensive guidelines for symptomatic management are widely used, regional preferences exist. In order to understand if the ...[more]